Showing results (71-80 of 80) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Journal of Athletic Training|January 16, 2019
The Omega-3 Index in National Collegiate Athletic Association Division I Collegiate Football AthletesAnthony Anzalone, Aaron Carbuhn, Lauren Jones, et al.World Journal of Gastroenterology|April 22, 2017
Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinomaLorenza Rimassa, Maria Reig, Giovanni Abbadessa, et al.Stroke|February 1, 2024
Association Between Hematoma Volume and Risk of Subsequent Ischemic Stroke: A MISTIE III and ATACH-2 AnalysisWilliam Harris, Jed H Kaiser, Vanessa Liao, et al.Circulation|August 3, 2016
Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical TrialBobak Heydari, Shuaib Abdullah, James V Pottala, et al.Frontiers in Cardiovascular Medicine|January 23, 2023
Bayesian network analysis of panomic biological big data identifies the importance of triglyceride-rich LDL in atherosclerosis developmentSzilard Voros, Aruna T Bansal, Michael R Barnes, et al.Journal of Medicinal Chemistry|January 5, 2002
Development of a virtual screening method for identification of "frequent hitters" in compound librariesOlivier Roche, Petra Schneider, Jochen Zuegge, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2021
Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II StudyRobin Kate Kelley, Bruno Sangro, William Harris, et al.Open Forum Infectious Diseases|October 30, 2025
Partial Oral Versus Intravenous Antibiotic Therapy for Endocarditis With Management by a Multidisciplinary Team: A Retrospective Cohort StudySami El-Dalati, Bennett Collis, Takaaki Kobayashi, et al.The Lancet. Oncology|April 8, 2018
Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled studyLorenza Rimassa, Eric Assenat, Markus Peck-Radosavljevic, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 10, 2025
Biliary Tract Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In OncologyAl B Benson, Michael I D'Angelica, Thomas Abrams, et al.Pageof 8